0001683168-20-000807.txt : 20200313
0001683168-20-000807.hdr.sgml : 20200313
20200313175316
ACCESSION NUMBER: 0001683168-20-000807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200313
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Matsuda Kazuko
CENTRAL INDEX KEY: 0001531140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33185
FILM NUMBER: 20714356
MAIL ADDRESS:
STREET 1: C/O MEDICINOVA, INC.
STREET 2: 4275 EXECUTIVE SQUARE, SUITE 650
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICINOVA INC
CENTRAL INDEX KEY: 0001226616
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330927979
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-373-1500
MAIL ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2020-03-13
0
0001226616
MEDICINOVA INC
MNOV
0001531140
Matsuda Kazuko
C/O MEDICINOVA, INC.
4275 EXECUTIVE SQUARE, SUITE 300
LA JOLLA
CA
92037
1
1
0
0
Chief Medical Officer
Common Stock
2020-03-13
4
P
0
2000
3.62
A
111476
D
The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
/s/ Yuichi Iwaki, attorney-in-fact
2020-03-13